Dr. Christopher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110Phone+1 314-454-8304Fax+1 314-454-5902
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2012 - 2016- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2010 - 2012
- Washington University in St. Louis School of MedicineClass of 2010
Certifications & Licensure
MO State Medical License 2013 - 2025
Clinical Trials
- Flotetuzumab for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Start of enrollment: 2021 May 20
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 278 citationsImmune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J. Christopher, Allegra A. Petti, Michael P. Rettig, Christopher A. Miller, Ezhilarasi Chendamarai
The New England Journal of Medicine. 2018-10-31 - 232 citationsExpression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in miceMatthew J. Christopher, Mahil Rao, Fulu Liu, Jill R. Woloszynek, Daniel C. Link
The Journal of Experimental Medicine. 2011-02-14 - 145 citationsRegulation of neutrophil homeostasis.Matthew J. Christopher, Daniel C. Link
Current Opinion in Hematology. 2007-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
